Annual FCF
-$25.25 M
-$9.31 M-58.44%
December 31, 2023
Summary
- As of February 7, 2025, PBLA annual free cash flow is -$25.25 million, with the most recent change of -$9.31 million (-58.44%) on December 31, 2023.
- During the last 3 years, PBLA annual FCF has fallen by -$21.39 million (-555.14%).
- PBLA annual FCF is now -68156.60% below its all-time high of $37.10 thousand, reached on December 31, 2012.
Performance
PBLA Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$2.12 M
-$1.14 M-116.11%
September 30, 2024
Summary
- As of February 7, 2025, PBLA quarterly free cash flow is -$2.12 million, with the most recent change of -$1.14 million (-116.11%) on September 30, 2024.
- Over the past year, PBLA quarterly FCF has increased by +$960.00 thousand (+31.17%).
- PBLA quarterly FCF is now -2070.26% below its all-time high of $107.60 thousand, reached on June 30, 2012.
Performance
PBLA Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$15.57 M
+$4.56 M+22.64%
September 30, 2024
Summary
- As of February 7, 2025, PBLA TTM free cash flow is -$15.57 million, with the most recent change of +$4.56 million (+22.64%) on September 30, 2024.
- Over the past year, PBLA TTM FCF has increased by +$9.68 million (+38.32%).
- PBLA TTM FCF is now -12033.33% below its all-time high of $130.50 thousand, reached on June 30, 2014.
Performance
PBLA TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
PBLA Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -58.4% | +31.2% | +38.3% |
| 3 y3 years | -555.1% | +78.3% | +26.6% |
| 5 y5 years | -957.8% | +78.3% | +26.6% |
PBLA Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -248.5% | at low | -116.1% | +78.3% | -115.0% | +42.7% |
| 5 y | 5-year | -821.8% | at low | -177.1% | +78.3% | -468.6% | +42.7% |
| alltime | all time | <-9999.0% | at low | -2070.3% | +78.3% | <-9999.0% | +42.7% |
Panbela Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$2.12 M(+116.1%) | -$15.57 M(-22.6%) |
| Jun 2024 | - | -$981.00 K(-89.6%) | -$20.13 M(-19.1%) |
| Mar 2024 | - | -$9.39 M(+204.9%) | -$24.89 M(-1.4%) |
| Dec 2023 | -$25.25 M(+58.4%) | -$3.08 M(-53.9%) | -$25.25 M(-7.1%) |
| Sep 2023 | - | -$6.68 M(+16.3%) | -$27.17 M(+23.0%) |
| Jun 2023 | - | -$5.74 M(-41.1%) | -$22.09 M(+4.2%) |
| Mar 2023 | - | -$9.75 M(+94.9%) | -$21.20 M(+33.1%) |
| Dec 2022 | -$15.94 M(+120.0%) | -$5.00 M(+213.9%) | -$15.94 M(+21.1%) |
| Sep 2022 | - | -$1.59 M(-67.2%) | -$13.16 M(+1.8%) |
| Jun 2022 | - | -$4.86 M(+8.3%) | -$12.93 M(+32.4%) |
| Mar 2022 | - | -$4.48 M(+101.2%) | -$9.76 M(+34.8%) |
| Dec 2021 | -$7.25 M(+88.0%) | -$2.23 M(+63.9%) | -$7.25 M(+18.2%) |
| Sep 2021 | - | -$1.36 M(-19.7%) | -$6.13 M(+10.7%) |
| Jun 2021 | - | -$1.69 M(-13.8%) | -$5.54 M(+17.8%) |
| Mar 2021 | - | -$1.97 M(+76.5%) | -$4.70 M(+21.9%) |
| Dec 2020 | -$3.85 M(+40.7%) | -$1.11 M(+45.5%) | -$3.85 M(+6.7%) |
| Sep 2020 | - | -$765.00 K(-10.6%) | -$3.61 M(+9.5%) |
| Jun 2020 | - | -$856.00 K(-23.6%) | -$3.30 M(+7.3%) |
| Mar 2020 | - | -$1.12 M(+28.4%) | -$3.08 M(+12.3%) |
| Dec 2019 | -$2.74 M(+14.7%) | -$872.00 K(+92.5%) | -$2.74 M(+35.0%) |
| Sep 2019 | - | -$453.00 K(-28.2%) | -$2.03 M(-8.4%) |
| Jun 2019 | - | -$631.00 K(-19.4%) | -$2.22 M(-14.2%) |
| Mar 2019 | - | -$783.00 K(+383.3%) | -$2.58 M(+8.2%) |
| Dec 2018 | -$2.39 M | -$162.00 K(-74.7%) | -$2.39 M(-20.6%) |
| Sep 2018 | - | -$640.00 K(-35.8%) | -$3.01 M(+14.4%) |
| Jun 2018 | - | -$997.00 K(+69.6%) | -$2.63 M(-9.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | -$588.00 K(-24.9%) | -$2.92 M(-14.2%) |
| Dec 2017 | -$3.40 M(+41.9%) | -$783.00 K(+200.0%) | -$3.40 M(-1.3%) |
| Sep 2017 | - | -$261.00 K(-79.7%) | -$3.45 M(-16.4%) |
| Jun 2017 | - | -$1.29 M(+20.0%) | -$4.13 M(+40.9%) |
| Mar 2017 | - | -$1.07 M(+29.5%) | -$2.93 M(+22.1%) |
| Dec 2016 | -$2.40 M(-38.5%) | -$828.00 K(-11.8%) | -$2.40 M(-2.0%) |
| Sep 2016 | - | -$939.00 K(+955.1%) | -$2.45 M(+2.6%) |
| Jun 2016 | - | -$89.00 K(-83.6%) | -$2.39 M(-32.4%) |
| Mar 2016 | - | -$542.00 K(-38.3%) | -$3.53 M(-9.4%) |
| Dec 2015 | -$3.90 M(+16.6%) | -$878.00 K(0.0%) | -$3.90 M(-6.9%) |
| Sep 2015 | - | -$878.00 K(-28.8%) | -$4.19 M(-24.1%) |
| Jun 2015 | - | -$1.23 M(+36.1%) | -$5.52 M(+29.3%) |
| Mar 2015 | - | -$907.00 K(-22.4%) | -$4.27 M(+27.6%) |
| Dec 2014 | -$3.34 M(+8154.3%) | -$1.17 M(-47.0%) | -$3.34 M(+61.3%) |
| Sep 2014 | - | -$2.21 M(<-9900.0%) | -$2.07 M(-1688.6%) |
| Jun 2014 | - | $16.30 K(-0.6%) | $130.50 K(+105.8%) |
| Mar 2014 | - | $16.40 K(-83.7%) | $63.40 K(-256.5%) |
| Dec 2013 | -$40.50 K(-209.2%) | $100.80 K(-3460.0%) | -$40.50 K(-76.5%) |
| Sep 2013 | - | -$3000.00(-94.1%) | -$172.30 K(-4.8%) |
| Jun 2013 | - | -$50.80 K(-41.9%) | -$181.00 K(+700.9%) |
| Mar 2013 | - | -$87.50 K(+182.3%) | -$22.60 K(-160.9%) |
| Dec 2012 | $37.10 K(-144.9%) | -$31.00 K(+165.0%) | $37.10 K(-45.5%) |
| Sep 2012 | - | -$11.70 K(-110.9%) | $68.10 K(-14.7%) |
| Jun 2012 | - | $107.60 K(-487.1%) | $79.80 K(-387.1%) |
| Mar 2012 | - | -$27.80 K | -$27.80 K |
| Dec 2011 | -$82.60 K | - | - |
FAQ
- What is Panbela Therapeutics annual free cash flow?
- What is the all time high annual FCF for Panbela Therapeutics?
- What is Panbela Therapeutics annual FCF year-on-year change?
- What is Panbela Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Panbela Therapeutics?
- What is Panbela Therapeutics quarterly FCF year-on-year change?
- What is Panbela Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Panbela Therapeutics?
- What is Panbela Therapeutics TTM FCF year-on-year change?
What is Panbela Therapeutics annual free cash flow?
The current annual FCF of PBLA is -$25.25 M
What is the all time high annual FCF for Panbela Therapeutics?
Panbela Therapeutics all-time high annual free cash flow is $37.10 K
What is Panbela Therapeutics annual FCF year-on-year change?
Over the past year, PBLA annual free cash flow has changed by -$9.31 M (-58.44%)
What is Panbela Therapeutics quarterly free cash flow?
The current quarterly FCF of PBLA is -$2.12 M
What is the all time high quarterly FCF for Panbela Therapeutics?
Panbela Therapeutics all-time high quarterly free cash flow is $107.60 K
What is Panbela Therapeutics quarterly FCF year-on-year change?
Over the past year, PBLA quarterly free cash flow has changed by +$960.00 K (+31.17%)
What is Panbela Therapeutics TTM free cash flow?
The current TTM FCF of PBLA is -$15.57 M
What is the all time high TTM FCF for Panbela Therapeutics?
Panbela Therapeutics all-time high TTM free cash flow is $130.50 K
What is Panbela Therapeutics TTM FCF year-on-year change?
Over the past year, PBLA TTM free cash flow has changed by +$9.68 M (+38.32%)